Retrospect on Exhibition ‖ Focus on Industry Hotspots and Release Brand Strength
Into Morimatsu ‖ Launch the Innovation Engine, See a New Vision of ”Import Substitution and Digital Intelligence First”
Exhibition Review ‖ To Depict New Blueprint of Biomedicine with Cutting-Edge Technologies and Latest Achievements
Pharmadule Morimatsu has successfully handed over China's First Modular mRNA Coronavirus Vaccine Factory within 7.5 month
Morimatsu International Listed in Hong Kong (2155. HK)